Authors


Laura Rezac, MD

Latest:

Creating a Telehealth Experience For Postoperative Appointments

Laura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.


Brian Nowosielski

Latest:

Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes

Researchers conduct a review to understand the efficacy and safety of topical minocycline for the treatment of moderate to severe papulopustular rosacea.


Jim Lee, MD, PhD

Latest:

Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology

"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.


Skylar Jeremias

Latest:

ICYMI: FDA Greenlights Yesintek, Sixth Biosimilar to Stelara, for Psoriasis and Psoriatic Arthritis

The FDA recently approved Yesintek for treating psoriasis, psoriatic arthritis, and IBD, with a 2025 launch expected.


Steven A. Davis, M.D.

Latest:

My experience with surface radiotherapy

Superficial radiation offers a newer, FDA-approved office-based option that is safe. Steven A. Davis, M.D., shares his experience using surface radiotherapy to treat his patients with non-melanoma skin cancer.


Maggi Ahmed, MD, PhD

Latest:

Combining Surgical Precision With Immunological Innovation in Vitiligo Treatment

Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.


Michael Somenek, MD

Latest:

Advancing Aesthetics: Innovations, Trends, and Patient-Centric Strategies in the Era of Weight Loss Medications

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.


Kaitlyn Bader, Assistant Managing Editor

Latest:

JAK Inhibitors as Flexible, Fast-Acting Option for Refractory AD

Raj Chovatiya, MD, PhD, MSCI, provides insights on the clinical advantages of JAK inhibitors for atopic dermatitis.



Guy Webster, MD, PhD, FAAD

Latest:

Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.


Elizabeth Berry, MD, FAAD

Latest:

Mastering Dermoscopy and Dysplastic Nevi

Elizabeth Berry, MD, FAAD, reviewed dysplastic nevi as risk markers and highlighted the need for more data on severe cases at AAD 2025.


Viviane Liao

Latest:

Overview of Prurigo Nodularis for Practicing Dermatology Clinicians

It is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.


Kristie L. Kahl

Latest:

Neoadjuvant Cemiplimab Induces Promising Pathologic Complete Response in CSCC

Neoadjuvant treatment with cemiplimab led to near or complete disappearance of cutaneous squamous cell carcinoma in almost 64% of patients set to undergo surgery.


Cole Villaflor

Latest:

Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician Perspectives

Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.


Maral Kibarian Skelsey, MD

Latest:

Maral Kibarian Skelsey, MD, Shares Insights Into DermTech’s 2-GEP Assay Success

DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.




Brittany Craiglow, MD

Latest:

Take-Home Points

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.


Rylan DeStefano

Latest:

Anti-Cancer Immunotherapy Treatments Spark Common Skin-Related Toxicities

Dermatologist Laura Ferris, MD, PhD, discusses skin-related toxicities as a result of immunotherapies for the treatment and management of cancers.


Amanda Piwonka

Latest:

Best Practices for Recruiting Talented Staff for Your Practice

Medical practices must go beyond simply offering competitive salaries and benefits packages to attract new talent and keep their best clinicians and administrative staff working for them.


Lynn Villaflor

Latest:

Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician Perspectives

Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.


Colleen Cotton, MD

Latest:

No Kidding: Tips for Treating Pediatric AD

What are the special considerations for treating pediatric atopic dermatitis? Test your knowledge and hear more from an expert.


Matthew Zirwas, MD

Latest:

What’s Next for Topical JAK Inhibitors?

His presentation at South Beach Symposium will feature Zirwas’ insights on JAK inhibitors, eczema treatments, and emerging therapies.


Walter Liszewski, MD

Latest:

Exploring the Intersection of Permanent Makeup and Dermatology

Walter Liszewski, MD, shares insights into discrepancies between permanent makeup and decorative tattoos and which patients may benefit from permanent makeup.


Fatuma-Ayaan Rinderknecht, MS, BA

Latest:

Organization Empowers Communities, Individuals to Celebrate the Skin They Are In

Celebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.



Tina Bhutani-Jacques, MD

Latest:

Case 2: Female, 15 Years Old

Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options. She also reviews the significance of patient assistance programs in facilitating patient access to and affordability of pharmaceutical therapies.



Seemal Desai, MD, FAAD

Latest:

Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)

Dermatology undergoes rapid transformation with new therapies, but faces challenges in payment reform, certification awareness, and balancing technology with patient care.


Tracey Vlahovic, DPM

Latest:

Advancing Nail Disorder Care by Bridging Podiatry and Dermatology

At the 2024 SDPA Fall Conference, Tracey Vlahovic, DPM, highlighted the need for interdisciplinary collaboration in nail disorder management, underscoring the importance of mutual learning between podiatry and dermatology.

© 2025 MJH Life Sciences

All rights reserved.